ezogabine has been researched along with linagliptin in 1 studies
Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (linagliptin) | Trials (linagliptin) | Recent Studies (post-2010) (linagliptin) |
---|---|---|---|---|---|
383 | 26 | 241 | 598 | 149 | 554 |
Protein | Taxonomy | ezogabine (IC50) | linagliptin (IC50) |
---|---|---|---|
Cytochrome P450 1A2 | Homo sapiens (human) | 0.3 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.2967 | |
Dipeptidyl peptidase 4 | Homo sapiens (human) | 0.0008 | |
Prolyl endopeptidase FAP | Mus musculus (house mouse) | 0.37 | |
Prolyl endopeptidase FAP | Homo sapiens (human) | 0.0799 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belavic, JM | 1 |
1 other study(ies) available for ezogabine and linagliptin
Article | Year |
---|---|
Annual drug update: 2011 in review.
Topics: Abatacept; Aminoglycosides; Carbamates; Drug Approval; Fentanyl; Fidaxomicin; Humans; Immunoconjugates; Indans; Linagliptin; Phenylenediamines; Proline; Purines; Quinazolines; Quinolones; United States; United States Food and Drug Administration | 2012 |